Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Filosa, Alessandro Dr. (1) Jeuthe, Sarah Dr. (1) Kammertöns, Thomas Dr. (3) Landthaler, Markus Prof. Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (1) Pezzutto, Antonio Prof. Dr. (2) Rathjen, Fritz Prof. Dr. (1) Sawamiphak, Suphansa Dr. (1) Willimsky, Gerald Dr. (1) Zauber, Henrik Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (9) (-) Selbach, Matthias Prof. Dr. (6) (-) Molekulare Immunologie und Gentherapie (9) (-) Proteom Dynamik (6) RNA Biologie und Posttranscriptionale Regulation (1) Translationale Onkologie solider Tumore (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) (-) 1997 (9) 1998 (9) 1999 (4) 2000 (8) 2001 (8) 2002 (8) 2003 (10) 2004 (10) 2005 (14) 2006 (3) 2007 (6) 2008 (8) 2009 (8) 2010 (10) 2011 (12) 2012 (10) 2015 (13) 2016 (12) 2017 (12) 2018 (10) 2019 (11) (-) 2020 (6) 2021 (16) 2022 (16) 2023 (9) 2024 (2) 15 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Selbach, Matthias Prof. Dr.Molekulare Immunologie und Gentherapie Proteom Dynamik19972020 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Januar 1997 / J Immunol Influence of gene modified (IL 7, IL 4, and B7) tumor cell vaccines on tumor antigen presentation S. Cayeux G. Richter G. Noffz B. Doerken T. Blankenstein 01. Januar 1997 / Eur J Immunol Lack of correlation between rejection of tumor cells co-expressing interleukin 2 and B7.1 and vaccine efficiency S. Cayeux G. Richter C. Becker C. Beck A. Aicher A. Pezzutto B. Doerken T. Blankenstein 01. Januar 1997 / Exp Hematol Successful retroviral mediated transduction of a receptor gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells A. Aicher J. Westermann S. Cayeux G. Willimsky K. Daemen T. Blankenstein W. Uckert B. Doerken A. Pezzutto 01. Januar 1997 / Methods Mol Med Methods for use of cytokine gene-modified tumor cells in immunotherapy of cancer Z. Qin T. Blankenstein 15. Juli 1997 / J Immunol Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte- macrophage colony-stimulating factor gene-modified tumor cells Z. Qin G. Noffz M. Mohaupt T. Blankenstein 15. Oktober 1997 / J Immunol Costimulatory signals through B7.1/CD28 prevent T cell apoptosis during target cell lysis P.T. Daniel A. Kroidl S. Cayeux R.C. Bargou T. Blankenstein B. Doerken 01. Januar 1997 / Gene Ther Loss of retroviral gene expression in bone marrow reconstituted mice correlates with down regulation of gene expression in long term culture initiating cells C. Lange T. Blankenstein 01. Januar 1997 / Hum Gene Ther Transient expression of SV 40 large T antigen by Cre/LoxP mediated site specific deletion in primary human tumor cells L.P. Li P.M. Schlag T. Blankenstein 01. Januar 1997 / J Immunol Down regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10 F. Salazar-Onfray J. Charo M. Petersson S. Freland G. Noffz Z.H. Qin T. Blankenstein H.G. Ljunggren R. Kiessling 18. März 2020 / Nucleic Acids Res The human ZC3H3 and RBM26/27 proteins are critical for PAXT-mediated nuclear RNA decay T. Silla M. Schmid Y. Dou W. Garland M. Milek K. Imami D. Johnsen P. Polak J.S. Andersen M. Selbach M. Landthaler T. Jensen Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. Januar 1997 / J Immunol Influence of gene modified (IL 7, IL 4, and B7) tumor cell vaccines on tumor antigen presentation S. Cayeux G. Richter G. Noffz B. Doerken T. Blankenstein
01. Januar 1997 / Eur J Immunol Lack of correlation between rejection of tumor cells co-expressing interleukin 2 and B7.1 and vaccine efficiency S. Cayeux G. Richter C. Becker C. Beck A. Aicher A. Pezzutto B. Doerken T. Blankenstein
01. Januar 1997 / Exp Hematol Successful retroviral mediated transduction of a receptor gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells A. Aicher J. Westermann S. Cayeux G. Willimsky K. Daemen T. Blankenstein W. Uckert B. Doerken A. Pezzutto
01. Januar 1997 / Methods Mol Med Methods for use of cytokine gene-modified tumor cells in immunotherapy of cancer Z. Qin T. Blankenstein
15. Juli 1997 / J Immunol Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte- macrophage colony-stimulating factor gene-modified tumor cells Z. Qin G. Noffz M. Mohaupt T. Blankenstein
15. Oktober 1997 / J Immunol Costimulatory signals through B7.1/CD28 prevent T cell apoptosis during target cell lysis P.T. Daniel A. Kroidl S. Cayeux R.C. Bargou T. Blankenstein B. Doerken
01. Januar 1997 / Gene Ther Loss of retroviral gene expression in bone marrow reconstituted mice correlates with down regulation of gene expression in long term culture initiating cells C. Lange T. Blankenstein
01. Januar 1997 / Hum Gene Ther Transient expression of SV 40 large T antigen by Cre/LoxP mediated site specific deletion in primary human tumor cells L.P. Li P.M. Schlag T. Blankenstein
01. Januar 1997 / J Immunol Down regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10 F. Salazar-Onfray J. Charo M. Petersson S. Freland G. Noffz Z.H. Qin T. Blankenstein H.G. Ljunggren R. Kiessling
18. März 2020 / Nucleic Acids Res The human ZC3H3 and RBM26/27 proteins are critical for PAXT-mediated nuclear RNA decay T. Silla M. Schmid Y. Dou W. Garland M. Milek K. Imami D. Johnsen P. Polak J.S. Andersen M. Selbach M. Landthaler T. Jensen